Cardiol Therapeutics Inc
NASDAQ:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
NASDAQ:CRDL
Watchlist
Price: 1.41 USD 2.17% Market Closed
Market Cap: 97.8m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CRDL Price Targets Summary
Cardiol Therapeutics Inc

Wall Street analysts forecast CRDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRDL is 7.27 USD with a low forecast of 6.28 USD and a high forecast of 8.44 USD.

CRDL Lowest Forecast
Wall Street Target
6.28 USD
345% Upside
CRDL Average Forecast
Wall Street Target
7.27 USD
416% Upside
CRDL Highest Forecast
Wall Street Target
8.44 USD
499% Upside
Lowest
Price Target
6.28 USD
345% Upside
Average
Price Target
7.27 USD
416% Upside
Highest
Price Target
8.44 USD
499% Upside
Cardiol Therapeutics Inc Competitors:
Price Targets
TBPH
Theravance Biopharma Inc
38% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
23% Downside
K
KILITCH
Kilitch Drugs (India) Ltd
12% Downside
UCB
Ucb SA
30% Upside
TBPH
Theravance Biopharma Inc
38% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
23% Downside
K
KILITCH
Kilitch Drugs (India) Ltd
12% Downside
UCB
Ucb SA
30% Upside
C
214370
Caregen Co Ltd
16% Upside
ETON
Eton Pharmaceuticals Inc
76% Upside
AXSM
Axsome Therapeutics Inc
61% Upside
PBH
Prestige Consumer Healthcare Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Cardiol Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cardiol Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cardiol Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
CRDL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRDL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRDL stock valuation using valuation multiples.
Wall Street Estimates
CRDL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRDL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRDL's stock price target?
Price Target
7.27 USD

According to Wall Street analysts, the average 1-year price target for CRDL is 7.27 USD with a low forecast of 6.28 USD and a high forecast of 8.44 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.